Healthcare -
Biotechnology - NASDAQ - US
$ 21.47
-2.36 %
$ 1.05 B
Market Cap
-11.36
P/E
ELVN - OTHER LIABILITIES
Other Liabilities ELVN - Enliven Therapeutics, Inc.
67 K
LAST VALUE
-97.89%
2 YEAR CAGR
-70.91%
5 YEAR CAGR
0.00%
10 YEAR CAGR